Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03141892 · ClinicalTrials.gov registry record

FreeStyle Libre Flash Glucose Monitoring System Accuracy Study

A clinical trial, sponsored by Abbott Diabetes Care.

Completed
Registry status
50
Enrollment target

NCT03141892 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03141892 has completed, sponsored by Abbott Diabetes Care.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

This is a pivotal, non-randomized, single arm, multi-center, prospective, non-significant risk study to evaluate the FreeStyle Libre Flash Glucose Monitoring System.

Interventions

  • DEVICE FreeStyle Libre Flash Glucose Monitoring System

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-04-13
Est. Completion 2017-05-30

Sponsor

Abbott Diabetes Care

26 total trials

What the Registry Record Tells You About NCT03141892

The ClinicalTrials.gov registry entry for NCT03141892 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which FreeStyle Libre Flash Glucose Monitoring System is the first listed.

NCT03141892 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03141892 about?

NCT03141892 is a clinical study titled "FreeStyle Libre Flash Glucose Monitoring System Accuracy Study". This is a pivotal, non-randomized, single arm, multi-center, prospective, non-significant risk study to evaluate the FreeStyle Libre Flash Glucose Monitoring System.

What is the current status of trial NCT03141892?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2017-04-13. Estimated completion is 2017-05-30.

What interventions are being tested in trial NCT03141892?

The interventions under investigation include: FreeStyle Libre Flash Glucose Monitoring System (DEVICE).

Who is sponsoring clinical trial NCT03141892?

This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.